Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 8/20 | 0.55 |
| ▸ | ACE | P12821 | 1/20 | 0.48 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.48 |
| ▸ | MDM4 | O15151 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | TNF | P01375 | 1/20 | 0.46 |
| ▸ | TLR2 | O60603 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17697136 | 0.94 | MDM2 (0.53) | PTPN1MDM2MDM4TP53TLR2 | |
| SCHEMBL30523139 | 0.94 | MDM2 (0.53) | PTPN1MDM2MDM4TP53TLR2 | |
| SCHEMBL23728660 | 0.94 | MDM2 (0.53) | PTPN1MDM2MDM4TP53TLR2 | |
| SCHEMBL23728661 | 0.94 | MDM2 (0.53) | PTPN1MDM2MDM4TP53TLR2 | |
| SCHEMBL29105490 | 0.91 | PTPN1 (0.49) | PTPN1ACEMDM2MDM4TP53 | |
| SCHEMBL29105492 | 0.91 | PTPN1 (0.49) | PTPN1ACEMDM2MDM4TP53 | |
| SCHEMBL12658044 | 0.91 | PTPN1 (0.53) | PTPN1MDM2MDM4TP53TLR2 | |
| SCHEMBL30523140 | 0.91 | PTPN1 (0.53) | PTPN1MDM2MDM4TP53TLR2 | |
| SCHEMBL7902079 | 0.91 | PTPN1 (0.51) | PTPN1ACEMDM2MDM4TP53 | |
| SCHEMBL22373690 | 0.90 | MDM2 (0.54) | PTPN1MDM2MDM4TP53TLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12433936-B2 | High-purity adrenocorticotropic hormone analogue and a large-scale preparation method thereof | Nanjing Hanxin Pharmaceutical Technology Co., Ltd. (CN) | 2025-10-07 | — | — | US | disclosed |
| EP-4602064-A1 | METHOD OF MANUFACTURING A PEPTIDE WITH A LYSINE DERIVATIVE | Bachem Holding AG (CH) | 2025-08-20 | — | — | EP | disclosed |
| WO-2024079043-A1 | METHOD OF MANUFACTURING A PEPTIDE WITH A LYSINE DERIVATIVE | BACHEM HOLDING AG (CH) | 2024-04-18 | — | — | WO | disclosed |
| US-20220401521-A1 | A HIGH-PURITY ADRENOCORTICOTROPIC HORMONE ANALOGUE AND A LARGE-SCALE PREPARATION METHOD THEREOF | Nanjing Hanxin Pharmaceutical Technology Co., Ltd. (CN) | 2022-12-22 | — | — | US | disclosed |
| WO-2022217395-A1 | HIGH-PURITY HUMAN CORTICOTROPIN OR ANALOG THEREOF, AND LARGE-SCALE PREPARATION METHOD THEREFOR | 南京汉欣医药科技有限公司 | 2022-10-20 | — | — | WO | disclosed |
| US-11419919-B1 | High-purity adrenocorticotropic hormone, analogue and a large-scale preparation method thereof | Nanjing Hanxin Pharmaceutical Technology Co., Ltd. (CN) | 2022-08-23 | — | — | US | disclosed |